Decreased expression of the GABAA receptor in fragile X syndrome

D'Hulst, Charlotte, De Geest, Natalie, Reeve, Simon P., Van Dam, Debby, De Deyn, Peter P., Hassan, Bassem A., Kooy, R. Frank·2006·Brain Research

Cited by (317)

Items 101–200 of 317

  1. Annual Research Review: The (epi)genetics of neurodevelopmental disorders in the era of whole‐genome sequencing – unveiling the dark matter
    Kiser, Dominik P., Rivero, Olga, Lesch, Klaus‐Peter · 2015 · Journal of Child Psychology and Psychiatry
  2. Resting-State EEG Oscillatory Dynamics in Fragile X Syndrome: Abnormal Functional Connectivity and Brain Network Organization
    Melle J. W. van der Molen, Cornelis Jan Stam, Maurits W. van der Molen · 2014 · PLoS ONE
  3. Pathological plasticity in fragile X syndrome.
    Martin, Brandon S., Huntsman, Molly M. · 2012 · Neural Plasticity
  4. Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients
    Charlotte D’Hulst, Inge Heulens, Nathalie Van der Aa, Karolien E. Goffin, Michel J. B. Koole, Kathleen Porke, Marc Van de Velde, Liesbeth Rooms, Wim Van Paesschen, Hilde Van Esch et al. · 2015 · PLoS ONE
  5. GABAergic circuit dysfunction in the Drosophila Fragile X syndrome model
    Cheryl L. Gatto, Daniel E. Pereira, Kendal S. Broadie · 2014 · Neurobiology of Disease
  6. Emerging Pharmacotherapies for Neurodevelopmental Disorders
    Daniel Z. Wetmore, Craig Curtis Garner · 2010 · Journal of Developmental & Behavioral Pediatrics
  7. Hyperexcitability and homeostasis in fragile X Syndrome.
    Liu, Xiaopeng, Kumar, Vipendra, Tsai, Nien-Pei, Auerbach, Benjamin D. · 2022 · Frontiers in Molecular Neuroscience
  8. Therapeutic approaches in the improvement of cognitive performance in Down syndrome
    de la Torre, Rafael, Dierssen, Mara · 2012 · Progress in Brain Research
  9. Subchronic Administration and Combination Metabotropic Glutamate and GABAB Receptor Drug Therapy in Fragile X Syndrome
    Laura K. K. Pacey, Sujeenthar Tharmalingam, David R. Hampson · 2011 · Journal of Pharmacology and Experimental Therapeutics
  10. Regulation of GABAA Receptor Subunit Expression in Substance Use Disorders
    Jeffrey Barker, Rochelle M. Hines · 2020 · International Journal of Molecular Sciences
  11. Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome
    Nianhui Zhang, Zechun Peng, Xiaoping Tong, A. Kerstin Lindemeyer, Yliana Cetina, Christine Huang, Richard W. Olsen, Thomas S. Otis, Carolyn R. Houser · 2017 · Experimental Neurology
  12. Temporal requirements of the fragile X mental retardation protein in modulating circadian clock circuit synaptic architecture
    Cheryl L. Gatto · 2009 · Frontiers in Neural Circuits
  13. Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
    Patricia Cogram, Robert M. J. Deacon, Jennifer L. Warner‐Schmidt, Melanie J. von Schimmelmann, Brett S. Abrahams, Matthew J. During · 2019 · Frontiers in Behavioral Neuroscience
  14. Molecular and Cellular Aspects of Mental Retardation in the Fragile X Syndrome: From Gene Mutation/s to Spine Dysmorphogenesis
    De Rubeis, Silvia, Fernández, Esperanza, Buzzi, Andrea, Di Marino, Daniele, Bagni, Claudia · 2012 · Advances in Experimental Medicine and Biology
  15. Keeping Excitation–Inhibition Ratio in Balance
    Sergei Kirischuk · 2022 · International Journal of Molecular Sciences
  16. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse
    Laura K. K. Pacey, Lilian Doss, Carlo Cifelli, Derek van der Kooy, Scott Patrick Heximer, David R. Hampson · 2011 · Molecular and Cellular Neuroscience
  17. The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells
    Francesca Zalfa, Vincenzo Panasiti, Simone Carotti, Maria Zingariello, Giuseppe Perrone, Laura Sancillo, Laura Pacini, Flavie Luciani, Vincenzo Roberti, Silvia D’Amico et al. · 2017 · Cell Death and Disease
  18. From FMRP Function to Potential Therapies for Fragile X Syndrome
    Ferzin Sethna, Changjong Moon, Hongbing Wang · 2013 · Neurochemical Research
  19. Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography—What Can be Interpreted from the Available Information?
    Niamh Mc Devitt, Louise Gallagher, Richard B. Reilly · 2015 · Brain Sciences
  20. The FRAXopathies: Definition, overview, and update
    Filomena Pirozzi, Elisabetta Tabolacci, Giovanni Neri · 2011 · American Journal of Medical Genetics Part A
  21. Reduced Lateral Inhibition Impairs Olfactory Computations and Behaviors in a Drosophila Model of Fragile X Syndrome
    Luis M. Franco, Zeynep Okray, Gerit Arne Linneweber, Bassem A. Hassan, Emre Yaksi · 2017 · Current Biology
  22. Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
    Amteshwar Singh Jaggi, Aalamjeet Kaur, Anjana Bali, Nirmal Singh · 2015 · Current Neuropharmacology
  23. Bryostatin-1 Restores Hippocampal Synapses and Spatial Learning and Memory in Adult Fragile X Mice
    Miao‐Kun Sun, Jarin Hongpaisan, Chol Seung Lim, Daniel L. Alkon · 2014 · Journal of Pharmacology and Experimental Therapeutics
  24. Targeted treatments in autism and fragile X syndrome
    Cihat Kağan Gürkan, Randi Jenssen Hagerman · 2012 · Research in Autism
  25. Fragile X Mental Retardation Protein in Learning-Related Synaptic Plasticity
    Valentina Mercaldo, Giannina Descalzi, Min Zhuo · 2009 · Molecules and Cells
  26. The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons
    Charles R. Tessier, Kendal S. Broadie · 2010 · Neurobiology of Disease
  27. Emerging pharmacologic treatment options for fragile X syndrome
    Craig A. Erickson, Tori L. Schaefer, Matthew H. Davenport · 2015 · The Application of Clinical Genetics
  28. Impaired Processing in the Primary Auditory Cortex of an Animal Model of Autism
    Renata Figueiredo Anomal, Etienne de Villers‐Sidani, Juliana Alves Brandão, R. M. B. Diniz, Marcos R. Costa, Rodrigo Neves Romcy-Pereira · 2015 · Frontiers in Systems Neuroscience
  29. The role of GABAergic neural circuits in the pathogenesis of autism spectrum disorder
    Jing Di, Jian Li, Bruce F. O’Hara, Ian L. Alberts, Lei Xiong, Jijun Li, Xiaohong Li · 2020 · International Journal of Developmental Neuroscience
  30. Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes
    Kathie L. Eagleson, Marı́a Clara Gravielle, Lisa J. Schlueter, Shelley J. Russek, David H. Farb, Pat R. Levitt · 2010 · Neuroscience
  31. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
    K. Ruby, K. Falvey, Randy J. Kulesza · 2015 · Neuroscience
  32. The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.
    Paola Sgadó, Mark Dunleavy, Sacha Genovesi, Giovanni Provenzano, Yuri Bozzi · 2011 · PubMed Central
  33. GABABreceptor‐mediated feed‐forward circuit dysfunction in the mouse model of fragile X syndrome
    Sarah Wahlstrom‐Helgren, Vitaly A. Klyachko · 2015 · The Journal of Physiology
  34. Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety
    Tori L. Schaefer, Matthew H. Davenport, Lindsay M. Grainger, Chandler K. Robinson, Anthony T. Earnheart, Melinda Stegman, Anna L. Lang, Amy A. Ashworth, Gemma Molinaro, Kimberly M. Huber et al. · 2017 · Journal of Neurodevelopmental Disorders
  35. Drosophila Studies on Autism Spectrum Disorders
    Yao Tian, Zi Chao Zhang, Junhai Han · 2017 · Neuroscience Bulletin
  36. Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome
    Florence Morin‐Parent, Camille M. Champigny, Angélina Lacroix, François Corbin, Jean‐François Lepage · 2019 · Translational Psychiatry
  37. Single cell transcriptomics reveals dysregulated cellular and molecular networks in a fragile X syndrome model
    Elisa R. Donnard, Huan Shu, Manuel G. Garber · 2022 · PLoS Genetics
  38. Adaptive control of synaptic plasticity integrates micro- and macroscopic network function
    Daniel N. Scott, Michael J. Frank · 2022 · Neuropsychopharmacology
  39. Interneuron Dysfunction in Syndromic Autism: Recent Advances
    Tomoyuki Takano · 2015 · Developmental Neuroscience
  40. Review of targeted treatments in fragile X syndrome
    Andrew Ligsay, Randi Jenssen Hagerman · 2016 · Intractable & Rare Diseases Research
  41. EEG abnormalities and seizures in genetically diagnosed Fragile X syndrome
    Takijah T. Heard, Sriram Ramgopal, Jonathan D. Picker, Sharyn A. Lincoln, Alexander Rotenberg, Sanjeev V. Kothare · 2014 · International Journal of Developmental Neuroscience
  42. Nuclear Respiratory Factor 1 (NRF-1) Controls the Activity Dependent Transcription of the GABA-A Receptor Beta 1 Subunit Gene in Neurons
    Zhuting Li, Meaghan Cogswell, Kathryn M. Hixson, Amy R. Brooks‐Kayal, Shelley J. Russek · 2018 · Frontiers in Molecular Neuroscience
  43. A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
    Clare L. Garcin, Shukry James Habib · 2017 · Results and problems in cell differentiation
  44. The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome
    Hampson, David R., Adusei, Daniel C., Pacey, Laura K.K. · 2011 · Biochemical Pharmacology
  45. Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention
    Balpreet Bhogal, Thomas A. Jongens · 2010 · Disease Models & Mechanisms
  46. Dysregulated Prefrontal Cortex Inhibition in Prepubescent and Adolescent Fragile X Mouse Model
    Ioannis Kramvis, Rhodé van Westen, Hanna C. A. Lammertse, Danai Riga, Tim S. Heistek, Alex Loebel, Sabine Spijker, Huibert D. Mansvelder, Rhiannon M. Meredith · 2020 · Frontiers in Molecular Neuroscience
  47. FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties
    Sarah A. Wolfe, Emily R. Workman, Chelcie F. Heaney, Farr Niere, Sanjeev V. Namjoshi, Luisa P. Cacheaux, Sean P. Farris, Michael R. Drew, Boris V. Zemelman, Robert Adron Harris et al. · 2016 · Nature Communications
  48. Pharmacotherapy for Fragile X Syndrome: Progress to Date
    Matthew H. Davenport, Tori L. Schaefer, Katherine Friedmann, Sarah E. Fitzpatrick, Craig A. Erickson · 2016 · Drugs
  49. Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome
    Anna O. Nguyen, Devin K. Binder, Iryna M. Ethell, Khaleel A. Razak · 2020 · Journal of Neurophysiology
  50. Molecular and Genetic Analysis of the Drosophila Model of Fragile X Syndrome
    Charles R. Tessier, Kendal S. Broadie · 2011 · Results and problems in cell differentiation
  51. Fragile X syndrome: from gene discovery to therapy
    Inge Heulens · 2010 · Frontiers in bioscience
  52. Epilepsy in four genetically determined syndromes of intellectual disability
    H. T. T. Leung, HOWARD A. RING · 2011 · Journal of Intellectual Disability Research
  53. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
    Weerasak Chonchaiya, Flora Tassone, Paul Ashwood, David R. Hessl, Andrea Schneider, Luis Campos, Danh V. Nguyen, Randi Jenssen Hagerman · 2010 · Human Genetics
  54. Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine
    Mathieu Di Miceli, B. Gronier · 2018 · Reviews on Recent Clinical Trials
  55. Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder
    Craig A. Erickson, Logan K. Wink, Maureen C. Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa B. Patrick, Christopher J. McDougle · 2013 · Journal of Autism and Developmental Disorders
  56. Downregulation of GABAA β Subunits is Transcriptionally Controlled by Fmr1p
    Andrew Hong, Aiying Zhang, Yang Ke, Abdeslem El Idrissi, Chang-Hui Shen · 2011 · Journal of Molecular Neuroscience
  57. Distribution of fragile X mental retardation protein in the human auditory brainstem
    K. Beebe, Yuan Wang, Randy Joseph Kulesza · 2014 · Neuroscience
  58. Mouse models of fragile X-related disorders
    Rob Willemsen, R. Frank Kooy · 2023 · Disease Models & Mechanisms
  59. GABAergic abnormalities in the fragile X syndrome.
    Van der Aa, Nathalie, Kooy, R. Frank · 2020 · European Journal of Paediatric Neurology
  60. A quantitative transcriptome reference map of the normal human brain
    Maria Caracausi, Lorenza Vitale, Maria Chiara Pelleri, Allison Piovesan, Samantha Bruno, Pierluigi Strippoli · 2014 · Neurogenetics
  61. CYFIP1 overexpression increases fear response in mice but does not affect social or repetitive behavioral phenotypes
    Catherine J. Fricano-Kugler, Aaron Gordon, Grace S. Shin, Kun Gao, Jade Nguyen, Jamee M Berg, Mary Starks, Daniel H. Geschwind · 2019 · Molecular Autism
  62. Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
    Hansen Wang, Sandipan Bankim Behari Pati, Lucas D. Pozzo‐Miller, Laurie C. Doering · 2015 · Frontiers in Cellular Neuroscience
  63. Seizures and Epilepsy in Autism Spectrum Disorder
    Frank Besag, Michael J. Vasey · 2020 · Child and Adolescent Psychiatric Clinics of North America
  64. Amygdala Regulation of Fear and Emotionality in Fragile X Syndrome
    Jose Luis Olmos-Serrano, Joshua G. Corbin · 2011 · Developmental Neuroscience
  65. Optimization of ribosome profiling using low-input brain tissue from fragile X syndrome model mice
    Botao Liu, Gemma Molinaro, Huan Shu, Emily E. Stackpole, Kimberly M. Huber, Joel D. Richter · 2018 · Nucleic Acids Research
  66. Translational Regulation of NeuroD1 Expression by FMRP: Involvement in Glutamatergic Neuronal Differentiation of Cultured Rat Primary Neural Progenitor Cells
    Se Jin Jeon, Ji‐Woon Kim, Ki Chan Kim, So Min Han, Hyo Sang Go, Jung Eun Seo, Chang Soon Choi, Jong Hoon Ryu, Chan Young Shin, Mi‐Ryoung Song · 2013 · Cellular and Molecular Neurobiology
  67. The α1, α2, α3, and γ2 subunits of GABAAreceptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development
    Tamara Stojanovic, Ivan Čapo, Eleonora Aronica, Homa Adle‐Biassette, Harald Höger, Werner Sieghart, Gábor Géza Kovács, Ivan Milenković · 2015 · The Journal of Comparative Neurology
  68. Advances in understanding fragile X syndrome and related disorders
    Liesbeth Rooms, R. Frank Kooy · 2011 · Current Opinion in Pediatrics
  69. Astroglial FMRP modulates synaptic signaling and behavior phenotypes in FXS mouse model
    Shan‐Xue Jin, Haruki Higashimori, Christina Schin, Alessandra Tamashiro Orrego, Yuqin Men, Ming Sum Ruby Chiang, Rachel Jarvis, Dan Cox, Larry A. Feig, Yongjie Yang · 2020 · Glia
  70. STDP and mental retardation: dysregulation of dendritic excitability in Fragile X syndrome
    Rhiannon M. Meredith · 2010 · Frontiers in Synaptic Neuroscience
  71. Combination Therapy in Fragile X Syndrome; Possibilities and Pitfalls Illustrated by Targeting the mGluR5 and GABA Pathway Simultaneously
    Shimriet Zeidler, Helen de Boer, Renate K. Hukema, Rob Willemsen · 2017 · Frontiers in Molecular Neuroscience
  72. Seizures and Epilepsy in Autism Spectrum Disorder
    Frank Besag, Michael J. Vasey · 2021 · Psychiatric Clinics of North America
  73. The Role of GABA Pathway Components in Pathogenesis of Neurodevelopmental Disorders
    Ekaterina V. Marilovtseva, Amal Abdurazakov, Artemiy O. Kurishev, V. A. Mikhailova, Вера Евгеньевна Голимбет · 2025 · International Journal of Molecular Sciences
  74. Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism
    Anastasia K. Neklyudova, Kirill Smirnov, Anna B. Rebreikina, Olga Martynova, Olga Sysoeva · 2022 · Genes
  75. Aberrant Dendritic Excitability: A Common Pathophysiology in CNS Disorders Affecting Memory?
    Michael W. Nestor, Dax A. Hoffman · 2012 · Molecular Neurobiology
  76. Altered Expression of GABAergic Markers in the Forebrain of Young and Adult Engrailed-2 Knockout Mice
    Giovanni Provenzano, Angela Gilardoni, Marika Maggia, Mattia Pernigo, Paola Sgadó, Simona Casarosa, Yuri Bozzi · 2020 · Genes
  77. Increasing our understanding of human cognition through the study of fragile X syndrome
    Denise Cook, Erin Nuro, Keith Kazuo Murai · 2013 · Developmental Neurobiology
  78. Involvement and Therapeutic Potential of the GABAergic System in the Fragile X Syndrome
    Inge Heulens, Charlotte D’Hulst, Sien Braat, Liesbeth Rooms, R. Frank Kooy · 2010 · The Scientific World JOURNAL
  79. FMRP regulates GABAA receptor channel activity to control signal integration in hippocampal granule cells
    Pan‐Yue Deng, Ajeet Kumar, Valeria Cavalli, Vitaly A. Klyachko · 2022 · Cell Reports
  80. Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome
    Pernille Bülow, Menahem Segal, Gary Jonathan Bassell · 2022 · International Journal of Molecular Sciences
  81. Hyperexcitability in the Olfactory Bulb and Impaired Fine Odor Discrimination in the Fmr1 KO Mouse Model of Fragile X Syndrome
    Praveen Kuruppath, Xue Lin, Frédéric Pouille, Shelly T. Jones, Nathan E. Schoppa · 2023 · Journal of Neuroscience
  82. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder
    Reymundo Lozano, Verónica Martínez‐Cerdeño, Randi Jenssen Hagerman · 2015 · Current Pharmaceutical Design
  83. Regional rates of brain protein synthesis are unaltered in dexmedetomidine sedated young men with fragile X syndrome: A L-[1-11C]leucine PET study
    Kathleen Schmidt, Inna Loutaev, Zenaide Quezado, Carrie A. Sheeler, Carolyn Beebe Smith · 2020 · Neurobiology of Disease
  84. The effects of prenatal H1N1 infection at E16 on FMRP, glutamate, GABA, and reelin signaling systems in developing murine cerebellum
    S. Hossein Fatemi, Timothy D. Folsom, Stephanie B. Liesch, Rachel E. Kneeland, Mahtab Karkhane Yousefi, PAUL D. THURAS · 2016 · Journal of Neuroscience Research
  85. A Recombinant Human Pluripotent Stem Cell Line Stably Expressing Halide-Sensitive YFP-I152L for GABAAR and GlyR-Targeted High-Throughput Drug Screening and Toxicity Testing
    Katharina Kuenzel, Oliver Friedrich, Daniel F. Gilbert · 2016 · Frontiers in Molecular Neuroscience
  86. Disrupted inhibitory plasticity and homeostasis in Fragile X syndrome
    Christian A. Cea-Del Rio, Alexia Nunez-Parra, Samuel Freedman, J. Keenan Kushner, Allyson Alexander, Diego Restrepo, Molly M. Huntsman · 2020 · Neurobiology of Disease
  87. Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
    Alessandra Tempio, Asma Boulksibat, Barbara Bardoni, Sébastien Delhaye · 2023 · Frontiers in Neuroscience
  88. Translational endpoints in fragile X syndrome
    Celine E. F. de Esch, Shimriet Zeidler, Rob Willemsen · 2013 · Neuroscience & Biobehavioral Reviews
  89. GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome
    Tori L. Schaefer, Amy A. Ashworth, Durgesh Tiwari, Madison P. Tomasek, Emma V. Parkins, Angela R. White, Andrew Snider, Matthew H. Davenport, Lindsay M. Grainger, Robert A. Becker et al. · 2021 · Frontiers in Psychiatry
  90. Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
    Luis A. Milla, Lucía López‐Corral, Jhanpool Rivera, Nolberto Zúñiga, Gabriela Pino, Alexia Nunez-Parra, Christian A. Cea-Del Rio · 2023 · Frontiers in Neuroscience
  91. Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model
    Amit Modgil, Thuy N. Vien, Michael A. Ackley, James Doherty, Stephen J. Moss, Paul A Davies · 2019 · Frontiers in Molecular Neuroscience
  92. Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications
    Ramkumar Aishworiya, Dragana D. Protic, Randi Jenssen Hagerman · 2022 · Journal of Neurology
  93. Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice
    Da Shi, Su Xu, Jaylyn Waddell, Susanna Scafidi, Steven Roys, Rao P. Gullapalli, Mary C. McKenna · 2012 · Journal of Neurochemistry
  94. Fragile X Syndrome FMRP Co-localizes with Regulatory Targets PSD-95, GABA Receptors, CaMKIIα, and mGluR5 at Fiber Cell Membranes in the Eye Lens
    Peter H. Frederikse, Anoop Nandanoor, Chinnaswamy Kasinathan · 2015 · Neurochemical Research
  95. Developmental changes in expression of inhibitory neuronal proteins in the Fragile X Syndrome mouse basolateral amygdala
    Sebila Kratovac, Joshua G. Corbin · 2013 · Brain Research
  96. Targeted treatments in fragile X syndrome
    Emma B. Hare, Randi Jenssen Hagerman, Reymundo Lozano · 2014 · Expert Opinion on Orphan Drugs
  97. Fragile X Syndrome: A Psychiatric Perspective
    Michael R. Tranfaglia · 2011 · Results and problems in cell differentiation
  98. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge
    Simone Carotti, Maria Zingariello, Maria Angela Francesconi, Laura D’Andrea, Maria Ujue Latasa, Leticia Colyn, Maite G. Fernández‐Barrena, Rocco Simone Flammia, Mario Falchi, Daniela Righi et al. · 2021 · Oncogene
  99. Hippocampal dysregulation of FMRP/mGluR5 signaling in engrailed-2 knockout mice
    Giovanni Provenzano, Paola Sgadó, Sacha Genovesi, Giulia Zunino, Simona Casarosa, Yuri Bozzi · 2015 · Neuroreport
  100. Compensatory Regulation of Excitation/Inhibition Balance in the Ventral Hippocampus: Insights from Fragile X Syndrome
    Costas Papatheodoropoulos · 2025 · Biology